Endogenous β-Carbolines as Clonidine-Displacing Substances

Annals of the New York Academy of Sciences

Volumn 1009, Issue , 2003, Pages 157-166

  Robinson, E S J ^a   Anderson, N J ^a   Crosby, J ^b   Nutt, D J ^a   Hudson, A L ^a,c  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b Dept Anat Sch Med Sci U   (United Kingdom)

^c School of Medical Sciences   (United Kingdom)

Author keywords

Clonidine displacing substance (CDS); Harmane; carboline

Indexed keywords

BETA CARBOLINE; BETA CARBOLINE DERIVATIVE; CLONIDINE DISPLACING SUBSTANCE; HARMAN; IMIDAZOLINE; LIGAND; TRYPTOLINE;

BINDING AFFINITY; BINDING SITE; CONFERENCE PAPER; DRUG BINDING SITE; DRUG MECHANISM; EXPERIMENT; EXTRACTION; FLUOROMETRY; GAS CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; LUNG; MASS SPECTROMETRY; NOMENCLATURE; NONHUMAN; PINEAL BODY; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION; SYNTHESIS; TISSUE;

MAMMALIA;

EID: 1342284213     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1304.018     Document Type: Conference Paper

References (50)

1. HUDSON, A.L., et al. 1999. Harmane, norharmane and tetrahydro-β- carboline have high affinity for rat imidazoline binding sites. Br. J. Pharmacol. 126: 2P.
2. HUSBANDS, S.M. 2001. β-Carboline binding to imidazoline receptors. Drug Alcohol Depend. 64: 203-208.
3. AIRAKSINEN, M.M. & I. KARI. 1981. β-Carbolines, psychoactive compounds in the mammalian body. Part I: occurrence, origin and metabolism. Med. Biol. 59: 21-34.
4. ATLAS, D. & Y. BURNSTEIN. 1984. Isolation and partial purification of clonidine-displacing endogenous brain substance. Eur. J. Biochem. 144: 287-293.
5. LI, G., et al. 1994. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
6. PRELL, G.D., et al. 2003. Imidazoleacetic acid-ribotide is an endogenous imidazoline receptor (IR) ligand. Presented at the Fourth International Symposium on Agmatine and Imidazoline Systems, San Diego, April 2003.
7. ATLAS, D. & Y. BURNSTEIN. 1984. Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett. 170: 387-390.
8. SINGH, G., et al. 1995. Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung. Naunyn-Schmiedberg's Arch. Pharmacol. 351: 17-26.
9. PARKER, C.A., et al. 1999. Tryptophan: a distinct but biologically inactive component of clonidine-displacing substance. Br. J. Pharmacol. 127: 72P.
10. MC ISSAC, W.M. 1961. Formation of 1-methyl-6-methoxy-1,2,3,4-tetrahydro- 2-carboline under physiological conditions. Biochem. Biophys. Acta 52: 607-609.
11. SHOEMAKER, D.W., et al. 1980. Identification of harmane in the rat arcuate nucleus. Naunyn-Schmiedeberg's Arch. Pharmacol. 310: 227-230.
12. BIDDER, T.G., et al. 1980. Harmane in human platelets. Life Sci. 25: 157-164.
13. ZHENG, W., et al. 2000. Determination of harmane and harmine in human blood using reversed-phased high performance liquid chromatography and fluorescence detection. Anal. Biochem. 279: 125-129.
14. FEKKES, D. & W.T. BODE. 1993. Occurrence and partition of the β-carboline norharmane in rat organs. Life Sci. 52: 2045-2054.
15. FEKKES, D., et al. 1992. Norharmane, a normal body constituent. Lancet 339: 506.
16. HONECKER, H. & H. ROMMELSPACHER. 1978. Tetrahydroharmane (tetrahydro-β-carboline), a physiologically occurring compound of indole metabolism. Naunyn Schmiedeberg's Arch. Pharmacol. 305: 135-141.
17. BARKER, S.A., et al. 1979. Identification and quantification of 1,2,3,4-tetrahydro-β-carboline, 2-methyl-1,2,3,4-tetrahydro-β- carboline, and 6-methoxy-1,2,3,4-tetrahydro-β-carboline as in vivo constituents of rat brain and adrenal gland. Biochem. Pharmacol. 30: 9-17.
18. SHOEMAKER, D.W., J.T. CUMMINS & T.G. BIDDER. 1978. β-carbolines in rat arcuate nucleus. Neurosci. 3: 233-239.
19. KARI, I., et al. 1983. Mass spectrometric identification of 6-methoxy-1,2,3,4-tetrahydro-β-carboline in pineal gland. In Recent Developments in Biochemistry, Medicine and Environmental Research. Vol 8: 19-24. Elsevier. Amsterdam, The Netherlands.
20. BOSIN, T.R., et al. 1983. Presence of formaldehyde in biological media and organic solvents: artifactual formation of tetra-hydro-β-carbolines. Analyt. Biochem. 128: 287-293.
21. BROSSI, A. 1993. Mammalian alkaloids II. In The Alkaloids. G.A. Cordell, Ed.: 119-183. Academic Press. New York, NY.
22. ROMMELSPACHER, H., et al. 1976. On the mode of formation of tetrahydro-β-carbolines. Life Sci. 18: 81-88.
23. SUSILO, R. & H. ROMMELSPACHER. 1987. Formation of a β-carboline (1,2,3,4-tetrahydro-1-methyl-β-carboline-1-carboxylic acid) following intracerebro-ventricular injection of tryptamine and pyruvic acid. Naunyn-Schmiedeberg's Arch. Pharmacol. 335: 70-76.
24. SUSILO, R. & H. ROMMELSPACHER. 1988. Formation of 1-methyl-β-carbolines in rats from their possible carboxylica acid precursor. Naunyn-Schmiedeberg's Arch. Pharmacol. 335: 566-571.
25. ROMMELSPACHER, H., et al. 1980. 1-Methyl-β-carboline (harmane) a potent inhibitor of bezodiadepine receptor binding. Naunyn Schmiedeberg's Arch. Pharmacol. 314: 97-100.
26. 3H]-diazepam binding in mouse brain. Life Sci. 28: 2257-2263.
27. MAY, T., et al. 1994. Comparison of the in vitro binding characteristics of the β-carbolines harmane and norharmane in rat brain and liver and bovine adrenal medulla. Naunyn Schmiedeberg's Arch. Pharmacol. 349: 308-317.
28. KELLER, K.J., et al. 1976. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates. J. Pharmacol. Exp. Ther. 198: 619-625.
29. FAIVRE, V., et al. 2000. Ligand interaction with the purified serotonin transporter in solution and at the air/water interface. FEBS Lett. 471: 56-60.
30. LICHTENBERG-KRAAG, B., et al. 1997. The natural β-carbolines facilitate inositol phosphate accumulation by activating small G-proteins in human neuroblastoma cells (SHSY5Y). Neuropharmacology 36: 1771-1778.
31. KLINKER, J.F., et al. 1997. Activation by β-carbolines of G-proteins in HL-60 membranes and the bovine retinal G-protein transducin in a receptor independent manner. Biochem. Pharmacol. 53: 1621-1626.
32. 3H]β-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver. Biochem. Pharmacol. 57: 511-20.
33. TIARA, Z., et al. 1997. Intercalationof six β-carboline derivatives into DNA. Jap. J. Toxicol. Environ. Health 43: 83-91.
34. 3H]β-carboline) binding sites in the rat brain. Eur. J. Pharmacol. 147: 163-171.
35. GLENNON, R.A., et al. 2000. Binding of β-carbolines and related serotonin (5-HT2 and 5-HT 1A) dopamine (D2) benzodiazepine receptors. Drug Alcohol Depend. 60: 121-132.
36. 1- imidazoline receptors. Br. J. Pharmacol. 129: 1057-1059.
37. MACKINNES, N. & S.L. HANDLEY. 2002. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I2-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine. Br. J. Pharmacol. 135: 1227-1234.
38. ADELL, A., et al. 1996. Action of harmane (1-methyl-β-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat. Neuropharmacology 8: 1101-1107.
39. HUDSON, A.L., et al. 1999b. Novel selective compounds for the investigation of imidazoline receptors. Annals. N. Y. Acad. Sci. 881: 81-91.
40. CAPPENDIKJ, S.L.T., D. FEKKES & M.R. DZOLJIC. 1994. The inhibitory effect of norharmane on morphine withdrawal syndrome in rats: comparison with ibogaine. Behav. Brain Res. 65: 117-119.
41. 2 receptors. Eur. J. Pharmacol. 353: 123-135.
42. WIBLE, J.H., et al. 1996. Cardiovascular effects of β-carbolines in conscious rats. Hypertens. Res. 19: 161-170.
43. JACKSON, H.C. & D.J. NUTT. 1996. Imidazoline receptors and ingestion. In Drug Receptor Subtypes and Ingestive Behaviour. Cooper, S.J. & P.G. Clifton, Eds.: 267-83. Academic Press. London.
44. MORGAN, N.G., et al. 2003. Comparative effects of efaroxan and β-carbolines on the secretory activity of rodent and human β cells. Ann. N. Y. Acad. Sci. This volume.
45. EDWARDS , M .M. 2003. Imidazoline ligands and feeding behaviour: the role of imidazoline binding sites. Ph.D. thesis, University of Bristol, Bristol, UK.
46. ROMMELSPACHER, H., et al. 1977. Pharmacological properties of tetrahydronorharmane (tryptoline). Naunyn-Schmiederberg's Arch. Pharmacol. 298: 83-91.
47. COLLINS, M.A. 2002. Alkaloids, alcohol and Parkinson's disease. Parkinsonism Relat. Disord. 8: 417-422.
48. DE MEESTER, C. 1995. Genotoxic potential of β-carbolines: a review. Mutation Res. Rev. Gen. Toxicol. 7. 339: 139-153.
49. GEARHART, D.A., et al. 2000. Increased β-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol. Dis. 7: 201-211.
50. GEARHART, D.A., P.F. TOOLE & J.W. BEEACH. 2002. Identification of brain proteins that interact with 2-methylnorharman. An analog of the Parkinsonian-inducing toxin, MPP+. Neurosci. Res. 44: 255-265.